Bitdeer Technologies
BTDR
Mawson Infrastructure
MIGI
Digihost Technology
DGHI
Canaan
CAN
Intchains Group
ICG
US Stock MarketDetailed Quotes
SNY Sanofi
- 54.950
- +0.060+0.11%
Close Feb 26 16:00 ET
- 54.810
- -0.140-0.25%
Pre 05:33 ET
137.77BMarket Cap23.66P/E (TTM)
55.200High54.570Low1.82MVolume54.600Open54.890Pre Close100.21MTurnover0.08%Turnover Ratio23.66P/E (Static)2.51BShares58.97052wk High1.70P/B124.47BFloat Cap43.38152wk Low1.95Dividend TTM2.27BShs Float58.970Historical High3.55%Div YieldTTM1.15%Amplitude8.844Historical Low54.962Avg Price1Lot Size
Sanofi News
Sanofi's Sustained Revenue Growth Potential: Buy Rating Justified by Extended Amvuttra Royalties
CDC A(H5N1) Bird Flu Response Update February 26, 2025; Confirmed 3 Human Cases Of H5 Bird Flu In People Who Became Ill In 2025 - Website
U.S. to Spend up to $1B for Bird Flu Response
Scribe Therapeutics to Participate in Upcoming Conferences
Enveda Gains Backing From Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M
Sanofi Target Raised to EUR125 From EUR100 by Intron Health
Sanofi Raised to Buy From Hold by Intron Health
Duvakitug, co-developed by Sanofi (SNY.US) and Teva (TEVA.US), is expected to enter phase 3 clinical trials in the second half of the year.
Sanofi (SNY.US) and Teva (TEVA.US) recently announced the detailed results obtained from their jointly developed monoclonal antibody duvakitug in the phase 2 clinical trial RELIEVE UCCD.
Sanofi Obtains Regulatory Approval for Blood Cancer Drug Sarclisa in Japan
Press Release: Sarclisa Approved in Japan for Patients With Newly Diagnosed Multiple Myeloma
Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency -- Barrons.com
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
Sanofi and Teva Report New Outcomes From Phase IIb Trial of Duvakitug
The Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis
Sanofi, Teva Pharmaceuticals Inflammatory Bowel Diseases' Drug Trial Shows Positive Results
Notable Healthcare Headlines for the Week: UnitedHealth, Moderna, Sanofi in Focus
Sanofi (SNY): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
Express News | Teva and Sanofi Present New Positive Phase 2B Study Results at Ecco 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-Tl1a) in Ulcerative Colitis and Crohn’s Disease
Sanofi Consumer Healthcare India's Net Profit Declines in Fiscal Q3
First Meeting of CDC Vaccine Advisory Panel Under RFK Jr. Postponed
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
